基本信息
浏览量:391
职业迁徙
个人简介
Mark Emberton’s principal interests lie in trying to improve diagnostic and therapeutic pathways for men with prostate cancer, principally through the use of novel imaging techniques and minimally-invasive treatments. He is the principal investigator in a number of studies in this area. Patients referred to UCLH will have the opportunity to take part in these studies. For instance, men with a clinical suspicion of prostate cancer can currently take part in the PROMIS trial. This involves evaluating whether MRI is able to diagnose prostate cancer better. Men taking part in these trials will all have a biopsy. Men who do not wish to part in the trial, can still have a standard care pathway biopsy of their prostate.
Mark Emberton and his team of researchers have initiated a clinical innovation programme exploring the role of focal therapy in men with prostate cancer. This involves treating only the areas of prostate cancer rather than the whole gland. Again, there are a number of trials up and running into which men can be recruited, provided that they fulfil the eligibility criteria. The trials are conducted as part of routine care and have as their aim the treatment of the prostate cancer with preservation of the surrounding tissue. It is damage to surrounding areas (from surgery or radiotherapy) that can give rise to erectile dysfunction, incontinence and back passage problems (diarrhoea, bleeding, pain). This, so far, has yielded very promising results with absence of erectile dysfunction and an avoidance of urinary incontinence. We use a number of technologies such as High Intensity Focused Ultrasound (HIFU) which uses soundwaves to heat and destroy small areas of tissue. We also are running the early trials looking at the role of photodynamic therapy.
Specialties
Prostate cancer
Research interests
Prostate cancer
Focal therapy
Non-invasive diagnosis
MRI scan
Active surveillance
Salvage therapy
High intesntivy focused ultrasound
Photo-dynamic therapy
Vascular targeted therapy
Photo therapy
Cyrosurgery
Mark Emberton and his team of researchers have initiated a clinical innovation programme exploring the role of focal therapy in men with prostate cancer. This involves treating only the areas of prostate cancer rather than the whole gland. Again, there are a number of trials up and running into which men can be recruited, provided that they fulfil the eligibility criteria. The trials are conducted as part of routine care and have as their aim the treatment of the prostate cancer with preservation of the surrounding tissue. It is damage to surrounding areas (from surgery or radiotherapy) that can give rise to erectile dysfunction, incontinence and back passage problems (diarrhoea, bleeding, pain). This, so far, has yielded very promising results with absence of erectile dysfunction and an avoidance of urinary incontinence. We use a number of technologies such as High Intensity Focused Ultrasound (HIFU) which uses soundwaves to heat and destroy small areas of tissue. We also are running the early trials looking at the role of photodynamic therapy.
Specialties
Prostate cancer
Research interests
Prostate cancer
Focal therapy
Non-invasive diagnosis
MRI scan
Active surveillance
Salvage therapy
High intesntivy focused ultrasound
Photo-dynamic therapy
Vascular targeted therapy
Photo therapy
Cyrosurgery
研究兴趣
论文共 1128 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
EUROPEAN UROLOGYno. 1 (2024): 35-46
Lara Rodríguez‐Sánchez,Robert Reiter, Alejandro Rodríguez,Mark Emberton,Theo de Reijke,Eva M. Compérat, Alberto Bossi,Rafael Sanchez‐Salas
BJU International (2024)
BJU INTERNATIONAL (2024)
Lara Rodriguez-Sanchez,Mark Emberton,Theo de Reijke,Phillip Stricker,Bernardino Minana,Fernando Bianco, Jose Luis Dominguez Escrig,Anna Lantz,Rafael Sanchez-Salas
WORLD JOURNAL OF MENS HEALTHno. 2 (2024): 245-255
CoRR (2024)
引用0浏览0EI引用
0
0
Lara Rodríguez-Sánchez,Robert Reiter, Alejandro Rodríguez,Mark Emberton,Theo de Reijke,Eva M Compérat, Alberto Bossi,Rafael Sanchez-Salas
BJU international (2024)
MEDICAL IMAGE ANALYSIS (2024): 103030-103030
World Journal of Urologyno. 1 (2024): 1-9
Ugo Giovanni Falagario,Francesco Pellegrino, Antonio Fanelli, Francesco Guzzi,Riccardo Bartoletti,Hannes Cash,Christian Pavlovich,Mark Emberton,Giuseppe Carrieri,Gianluca Giannarini
PROSTATE CANCER AND PROSTATIC DISEASESpp.1-10, (2024)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn